Drug details

Astagraf XL (tacrolimus extended-release capsules)

type of Immunosuppressants, Calcineurin Inhibitors

Astagraf XL (tacrolimus) Extended-Release Capsules is a macrolide immunosuppressant used with other medicines to help prevent organ rejection in people who have had a kidney transplant.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• loss of appetite,
• fever,
• shortness of breath,
• confusion,
• chills,
• tiredness,
• chest pain,
• fluttering in your chest,
• seizure,
• pounding in your neck or ears,
• muscle aches,
• flu-like symptoms,
• sweating,
• weakness,
• cough,
• little or no urination,
• increased thirst,
• increased urination,
• fruity breath odor,
• headaches,
• swelling in your feet or ankles,
• drowsiness,
• irregular heartbeats,
• vision changes,
• fast or pounding heartbeats,
• sudden dizziness,
• hunger,
• general ill feeling,
• pale skin, and
• loss of movement,
• muscle weakness or limp feeling,
• cold hands and feet
• bone pain,
• behavior changes,
• pain or swelling near your transplanted organ,
• jerky muscle movements,
• slow reflexes,
• painful skin sores,
• skin warmth or redness,

The following drugs are related to Astagraf XL, either as a replacement or used together:

• Prograf (tacrolimus)
• Rystiggo (rozanolixizumab-noli injection)